We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEF icon
4426
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$7.77K ﹤0.01%
83
-482
-85% -$44.8K
SURG icon
4427
SurgePays
SURG
$7.59M
$7.77K ﹤0.01%
2,435
+2,376
+4,027% +$8.98K
CADL icon
4428
Candel Therapeutics
CADL
$769M
$7.76K ﹤0.01%
1,252
-2,450
-66% -$18.4K
LIVE icon
4429
Live Ventures
LIVE
$30.7M
$7.76K ﹤0.01%
342
+83
+32% +$2.1K
NEPH icon
4430
Nephros
NEPH
$47.6M
$7.75K ﹤0.01%
3,673
-728
-17% -$1.57K
DVLT
4431
Datavault AI
DVLT
$256M
$7.71K ﹤0.01%
3,051
+3,009
+7,164% +$10.2K
NUTX
4432
Nutex Health
NUTX
$1.35B
$7.71K ﹤0.01%
1,296
+770
+146% +$5.55K
HHS icon
4433
Harte-Hanks
HHS
$18.5M
$7.71K ﹤0.01%
949
+756
+392% +$5.51K
SNAL icon
4434
Snail Inc
SNAL
$40M
$7.7K ﹤0.01%
1,789
+154
+9% +$726
OXBR icon
4435
Oxbridge Re Holdings
OXBR
$10.6M
$7.68K ﹤0.01%
3,227
-3,597
-53% -$6.08K
AMIX
4436
Autonomix Medical
AMIX
$5.04M
$7.68K ﹤0.01%
19
+15
+375% +$14.8K
LNZA icon
4437
LanzaTech
LNZA
$70.1M
$7.68K ﹤0.01%
42
-18
-30% -$4.59K
GHSI
4438
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$7.65K ﹤0.01%
762
-236
-24% -$2.09K
IMG
4439
DELISTED
CIMG Inc
IMG
$7.64K ﹤0.01%
239
-54
-18% -$1.76K
BDL icon
4440
Flanigan's Enterprises
BDL
$76.2M
$7.63K ﹤0.01%
284
-41
-13% -$1.11K
NXGL icon
4441
NexGel
NXGL
$3.34M
$7.63K ﹤0.01%
3,533
-393
-10% -$865
NMAD
4442
Nomad Power Solutions
NMAD
$71.9M
$7.62K ﹤0.01%
3,217
-724
-18% -$2.02K
ALOY
4443
REalloys Inc
ALOY
$886M
$7.62K ﹤0.01%
2,821
-102
-3% -$288
SVT
4444
DELISTED
Servotronics
SVT
$7.62K ﹤0.01%
640
-6
-0.9% -$74
SCKT icon
4445
Socket Mobile
SCKT
$17.6M
$7.6K ﹤0.01%
7,040
-341
-5% -$399
PDYN icon
4446
Palladyne AI
PDYN
$305M
$7.6K ﹤0.01%
4,748
-168
-3% -$289
TLIS
4447
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$7.6K ﹤0.01%
877
-50
-5% -$443
GROV icon
4448
Grove Collaborative
GROV
$45.3M
$7.57K ﹤0.01%
4,277
-6,807
-61% -$10.9K
KULR icon
4449
KULR Technology Group
KULR
$127M
$7.57K ﹤0.01%
2,395
+1,618
+208% +$5.8K
DCOY
4450
Decoy Therapeutics
DCOY
$2.04M
$7.56K ﹤0.01%
18
+12
+200% +$7.93K

Similar funds

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.